These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15692979)

  • 1. Drug efflux transporters in rheumatoid arthritis: comment on the article by Kremer.
    Hider SL; Hoggard P; Khoo S; Back D; Bruce IN
    Arthritis Rheum; 2005 Feb; 52(2):670; author reply 672. PubMed ID: 15692979
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate and long-term treatment of rheumatic disease: comment on the article by Kremer.
    Ranganathan P; McLeod HL
    Arthritis Rheum; 2005 Feb; 52(2):670-1; author reply 672. PubMed ID: 15692997
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased MDR1 P-glycoprotein expression in methotrexate resistance: comment on the article by Yudoh et al.
    Rahman P; Hefferton D; Robb D
    Arthritis Rheum; 2000 Jul; 43(7):1661-2. PubMed ID: 10902777
    [No Abstract]   [Full Text] [Related]  

  • 4. Overexpression of P-glycoprotein on fibroblast-like synoviocytes in refractory rheumatoid arthritis patients: a potential mechanism for multidrug resistance in rheumatoid arthritis treatment.
    Liu YM; Chen JW; Chen LX; Xie X; Mao N
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDR-ABC transporters: biomarkers in rheumatoid arthritis.
    Márki-Zay J; Tauberné Jakab K; Szerémy P; Krajcsi P
    Clin Exp Rheumatol; 2013; 31(5):779-87. PubMed ID: 23711386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis.
    Ranganathan P; McLeod HL
    Arthritis Rheum; 2006 May; 54(5):1366-77. PubMed ID: 16645965
    [No Abstract]   [Full Text] [Related]  

  • 7. Methotrexate: vital new information about a middle aged drug.
    Giannini EH
    J Rheumatol; 2002 Oct; 29(10):2031-3. PubMed ID: 12375307
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacogenetics of methotrexate.
    Hider SL; Bruce IN; Thomson W
    Rheumatology (Oxford); 2007 Oct; 46(10):1520-4. PubMed ID: 17586865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring methotrexate polyglutamates.
    Goodman S
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S24-6. PubMed ID: 21044429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis.
    Dervieux T; Weinblatt ME; Kivitz A; Kremer JM
    Ann Rheum Dis; 2013 Jun; 72(6):908-10. PubMed ID: 23161901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate pharmacogenetics in rheumatoid arthritis.
    Brinker RR; Ranganathan P
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S33-9. PubMed ID: 21044431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacogenetics of disease modifying anti-rheumatic drugs].
    Taniguchi A; Urano W; Tanaka E; Akama H; Yamanaka H; Kamatani N
    Nihon Rinsho; 2002 Dec; 60(12):2339-44. PubMed ID: 12510359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of quality and bioavailability of methotrexate in Thai patients with rheumatoid arthritis.
    Manorot M; Rojanasathien N; Louthrenoo W; Tonsuwannont W; Teekachunhatean S
    J Med Assoc Thai; 1998 Dec; 81(12):978-85. PubMed ID: 9916387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis.
    Vakily M; Amer F; Kukulka MJ; Andhivarothai N
    J Clin Pharmacol; 2005 Oct; 45(10):1179-86. PubMed ID: 16172183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritis.
    Debord J; Carpentier N; Sabot C; Bertin P; Marquet P; Treves R; Merle L; Lachâtre G
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):227-30. PubMed ID: 9587050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis.
    Tian H; Cronstein BN
    Bull NYU Hosp Jt Dis; 2007; 65(3):168-73. PubMed ID: 17922664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
    Carmichael SJ; Beal J; Day RO; Tett SE
    J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The issue of bioavailability of oral low dose methotrexate: should we choose only 10 mg of MTX a week in conjunction with anti-TNF therapy?
    Zeidler H
    Ann Rheum Dis; 2014 Aug; 73(8):e50. PubMed ID: 24764450
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal administration and dosage of methotrexate.
    Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S46-51. PubMed ID: 21044433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.